개정된 대한췌장담도학회 급성췌장염 임상진료지침: 중증도 평가 = Revised Clinical Practice Guideline of Korean Pancreatobiliary Association for Acute Pancreatitis: Severity Assessment

국문 초록 (Abstract)

급성췌장염의 중증도는 장기부전 여부 및 지속 시간, 국소합병증 여부를 고려하여 경증, 중등 중증, 중증으로 분류한다. 급성췌장염은 중증도에 따라 사망률과 합병증 이환율에 큰 차이를 보이므로 초기 급성췌장염 환자의 중증도 평가는 예후 예측, 중환자실 입실, 전원 등의 치료 방침 결정을 위해 중요하다. 급성췌장염 초기 중증도 평가를 위해 생체 징후를 통한 장기부전의 동반 여부 확인 및 영상/임상 검사를 통한 객관적 평가가 필요하며, BISAP, SIRS, APACHE-II 지표 등 여러 중증도 판정 기준을 이용한 평가를 고려할 것을 본 권고안을 통하여 권고한다.

다국어 초록 (Multilingual Abstract)

The severity of acute pancreatitis (AP) is classified into mild, moderately severe, and severe, considering the presence and duration of organ failure and local complications. Since patients with AP show a large difference in mortality and morbidity according to AP severity, evaluation of the severity of patients with AP in the early stage is important for predicting the prognosis and determining treatment plans including transfer to the intensive care unit or advanced facilities. In order to evaluate the initial severity of AP, it is necessary to confirm the presence of organ failure and objective evaluation using imaging or clinical examinations. In this guideline, it is recommended that evaluation using various severity indices such as bedside index for severity in acute pancreatitis (BISAP), systemic inflammatory response syndrome (SIRS), and acute physiology and chronic health evaluation (APACHE)-II scores be considered.
Korean J Pancreas Biliary Tract 2022;27(1):12-21

참고문헌 (Reference)

1 Farrell PR, "Who's at risk? A prognostic model for severity prediction in pediatric acute pancreatitis" 71 : 536-542, 2020

2 Caluianu EI, "Utilizing multiparameter scores and procalcitonin as prognosis markers for the degree of severity of acute pancreatitis" 43 : 311-317, 2017

3 Yasuda H, "Usefulness of urinary trypsinogen-2 and trypsinogen activation peptide in acute pancreatitis : a multicenter study in Japan" 25 : 107-117, 2019

4 Working Party of the British Society of Gastroenterology, "UK guidelines for the management of acute pancreatitis" 54 (54): iii1-iii9, 2005

5 Mofidi R, "The value of procalcitonin at predicting the severity of acute pancreatitis and development of infected pancreatic necrosis : systematic review" 146 : 72-81, 2009

6 Stimac D, "The role of nonenhanced magnetic resonance imaging in the early assessment of acute pancreatitis" 102 : 997-1004, 2007

7 Shen HN, "The effect of hospital volume on patient outcomes in severe acute pancreatitis" 12 : 112-, 2012

8 Liu G, "The early prognostic value of inflammatory markers in patients with acute pancreatitis" 43 : 330-337, 2019

9 Wu BU, "The early prediction of mortality in acute pancreatitis : a large population-based study" 57 : 1698-1703, 2008

10 Modrau IS, "The clinical value of procalcitonin in early assessment of acute pancreatitis" 100 : 1593-1597, 2005

11 Rau B, "The clinical value of human pancreas-specific protein procarboxypeptidase B as an indicator of necrosis in acute pancreatitis : comparison to CRP and LDH" 17 : 134-139, 1998

12 Kim JE, "The clinical outcome of elderly patients with acute pancreatitis is not different in spite of the different etiologies and severity" 54 : 256-260, 2012

13 Zhou H, "Severity stratification and prognostic prediction of patients with acute pancreatitis at early phase: a retrospective study" 98 : e15275-, 2019

14 Kolber W, "Serum urokinase-type plasminogen activator receptor does not outperform C-reactive protein and procalcitonin as an early marker of severity of acute pancreatitis" 7 : 305-, 2018

15 Pezzilli R, "Serum interleukin-6, interleukin-8, and beta 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein" 40 : 2341-2348, 1995

16 Wan J, "Serum creatinine level and APACHE-II score within 24 h of admission are effective for predicting persistent organ failure in acute pancreatitis" 2019 : 8201096-, 2019

17 Talamini G, "Serum creatinine and chest radiographs in the early assessment of acute pancreatitis" 177 : 7-14, 1999

18 Pezzilli R, "Serum and urine trypsinogen activation peptide in assessing post-endoscopic retrograde cholangiopancreatography pancreatitis" 39 : 108-110, 2010

19 Komolafe O, "Serum C-reactive protein, procalcitonin, and lactate dehydrogenase for the diagnosis of pancreatic necrosis" 4 : CD012645-, 2017

20 Rau BM, "Role of early multisystem organ failure as major risk factor for pancreatic infections and death in severe acute pancreatitis" 4 : 1053-1061, 2006

21 Talamini G, "Risk of death from acute pancreatitis. Role of early, simple"routine"data" 19 : 15-24, 1996

22 Tenner S, "Relationship of necrosis to organ failure in severe acute pancreatitis" 113 : 899-903, 1997

23 Paul J, "Recent advances in diagnosis and severity assessment of acute pancreatitis" 121 : 65-86, 2020

24 London NJ, "Rapid-bolus contrast-enhanced dynamic computed tomography in acute pancreatitis : a prospective study" 78 : 1452-1456, 1991

25 Ranson JH, "Prognostic signs and the role of operative management in acute pancreatitis" 139 : 69-81, 1974

26 Blamey SL, "Prognostic factors in acute pancreatitis" 25 : 1340-1346, 1984

27 Liang Y, "Procalcitonin, C-reactive protein, and neutrophil ratio contribute to the diagnosis and prognosis of severe acute pancreatitis" 48 : 2177-2186, 2019

28 Dias BH, "Procalcitonin strip test as an independent predictor in acute pancreatitis" 77 (77): 1012-1017, 2015

29 Yang CJ, "Predictors of severe and critical acute pancreatitis : a systematic review" 46 : 446-451, 2014

30 Jinno N, "Predictive factors for the mortality of acute pancreatitis on admission" 14 : e0221468-, 2019

31 Huang W, "Prediction of the severity of acute pancreatitis on admission by urinary trypsinogen activation peptide : a metaanalysis" 19 : 4607-4615, 2013

32 Banks PA, "Practice guidelines in acute pancreatitis" 101 : 2379-2400, 2006

33 Spanier BW, "Practice and yield of early CT scan in acute pancreatitis : a Dutch Observational Multicenter Study" 10 : 222-228, 2010

34 Johnson CD, "Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis" 53 : 1340-1344, 2004

35 Isenmann R, "Pancreatic necrosis : an early finding in severe acute pancreatitis" 8 : 358-361, 1993

36 Talamini G, "Pain relapses in the first 10 years of chronic pancreatitis" 171 : 565-569, 1996

37 Siriwardena AK, "PROCalcitoninbased algorithm for antibiotic use in Acute Pancreatitis(PROCAP) : study protocol for a randomised controlled trial" 20 : 463-, 2019

38 Malangoni MA, "Outcome of severe acute pancreatitis" 189 : 273-277, 2005

39 Shafiq F, "Outcome of patients with acute pancreatitis requiring intensive care admission : a retrospective study from a tertiary care center of Pakistan" 34 : 1082-1087, 2018

40 Ranson JH, "Objective early identification of severe acute pancreatitis" 61 : 443-451, 1974

41 Lankisch PG, "No strict correlation between necrosis and organ failure in acute pancreatitis" 20 : 319-322, 2000

42 Singla A, "National hospital volume in acute pancreatitis: analysis of the Nationwide Inpatient Sample 1998-2006" 11 : 391-397, 2009

43 Robin-Lersundi A, "Multidisciplinary approach to treating severe acute pancreatitis in a low-volume hospital" 43 : 2994-3002, 2019

44 Gliem N, "Management of severe acute pancreatitis : an update" 102 : 503-507, 2021

45 Vege SS, "Low mortality and high morbidity in severe acute pancreatitis without organ failure : a case for revising the Atlanta classification to include"moderately severe acute pancreatitis"" 104 : 710-715, 2009

46 Staubli SM, "Laboratory markers predicting severity of acute pancreatitis" 52 : 273-283, 2015

47 Yokoe M, "Japanese guidelines for the management of acute pancreatitis : Japanese Guidelines 2015" 22 : 405-432, 2015

48 Perez A, "Is severity of necrotizing pancreatitis increased in extended necrosis and infected necrosis?" 25 : 229-233, 2002

49 Viedma JA, "Inflammatory response in the early prediction of severity in human acute pancreatitis" 35 : 822-827, 1994

50 Simsek O, "Inflammatory mediators in the diagnosis and treatment of acute pancreatitis : pentraxin-3, procalcitonin and myeloperoxidase" 14 : 288-296, 2018

51 Hamada T, "Impact of hospital volume on outcomes in acute pancreatitis : a study using a nationwide administrative database" 49 : 148-155, 2014

52 Mole DJ, "Identifying risk factors for progression to critical care admission and death among individuals with acute pancreatitis : a record linkage analysis of Scottish healthcare databases" 6 : e011474-, 2016

53 Working Group IAP/APA Acute Pancreatitis Guidelines, "IAP/APA evidence-based guidelines for the management of acute pancreatitis" 13 (13): e1-e15, 2013

54 Nguyen GC, "Hospital volume as a predictor for undergoing cholecystectomy after admission for acute biliary pancreatitis" 39 : e42-e47, 2010

55 Kamal A, "Hospital admission volume does not impact the in-hospital mortality of acute pancreatitis" 19 : 21-28, 2017

56 Brown A, "Hemoconcentration is an early marker for organ failure and necrotizing pancreatitis" 20 : 367-372, 2000

57 Pezzilli R, "Hematocrit determination(HCT)as an early marker associated with necrotizing pancreatitis and organ failure" 22 : 433-435, 2001

58 Lankisch PG, "Has blood glucose level measured on admission to hospital in a patient with acute pancreatitis any prognostic value?" 1 : 224-229, 2001

59 Blum T, "Fatal outcome in acute pancreatitis : its occurrence and early prediction" 1 : 237-241, 2001

60 Muddana V, "Elevated serum creatinine as a marker of pancreatic necrosis in acute pancreatitis" 104 : 164-170, 2009

61 Murata A, "Effect of hospital volume on clinical outcome in patients with acute pancreatitis, based on a national administrative database" 40 : 1018-1023, 2011

62 Singh VK, "Early systemic inflammatory response syndrome is associated with severe acute pancreatitis" 7 : 1247-1251, 2009

63 Isenmann R, "Early severe acute pancreatitis : characteristics of a new subgroup" 22 : 274-278, 2001

64 Neoptolemos JP, "Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide : a multicentre study" 355 : 1955-1960, 2000

65 Flint R, "Early physiological response to intensive care as a clinically relevant approach to predicting the outcome in severe acute pancreatitis" 139 : 438-443, 2004

66 Kemppainen E, "Early localization of necrosis by contrast-enhanced computed tomography can predict outcome in severe acute pancreatitis" 83 : 924-929, 1996

67 Buter A, "Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis" 89 : 298-302, 2002

68 Larvin M, "Dynamic contrast enhanced computed tomography : a precise technique for identifying and localising pancreatic necrosis" 300 : 1425-1428, 1990

69 Alexakis N, "Duodenum-and spleen-preserving total pancreatectomy for end-stage chronic pancreatitis" 90 : 1401-1408, 2003

70 Lankisch PG, "Do we need a computed tomography examination in all patients with acute pancreatitis within 72 h after admission to hospital for the detection of pancreatic necrosis?" 36 : 432-436, 2001

71 De Bernardinis M, "Discriminant power and information content of Ranson's prognostic signs in acute pancreatitis : a meta-analytic study" 27 : 2272-2283, 1999

72 Bone RC, "Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine" 101 : 1644-1655, 1992

73 Bezmarevic M, "Correlation between procalcitonin and intra-abdominal pressure and their role in prediction of the severity of acute pancreatitis" 12 : 337-343, 2012

74 Italian Association for the Study of the Pancreas(AISP), "Consensus guidelines on severe acute pancreatitis" 47 : 532-543, 2015

75 Arvanitakis M, "Computed tomography and magnetic resonance imaging in the assessment of acute pancreatitis" 126 : 715-723, 2004

76 Leese T, "Comparison of three Glasgow multifactor prognostic scoring systems in acute pancreatitis" 75 : 460-462, 1988

77 Mounzer R, "Comparison of existing clinical scoring systems to predict persistent organ failure in patients with acute pancreatitis" 142 : 1476-e16-, 2012

78 Chatzicostas C, "Comparison of Ranson, APACHE II and APACHE III scoring systems in acute pancreatitis" 25 : 331-335, 2002

79 Papachristou GI, "Comparison of BISAP, Ranson's, APACHE-II, and CTSI scores in predicting organ failure, complications, and mortality in acute pancreatitis" 105 : 435-442, 2010

80 Greenberg JA, "Clinical practice guideline : management of acute pancreatitis" 59 : 128-140, 2016

81 Petrov MS, "Classification of the severity of acute pancreatitis : how many categories make sense?" 105 : 74-76, 2010

82 Banks PA, "Classification of acute pancreatitis--2012 : revision of the Atlanta classification and definitions by international consensus" 62 : 102-111, 2013

83 Talamini G, "Cigarette smoking : an independent risk factor in alcoholic pancreatitis" 12 : 131-137, 1996

84 Uchikov PA, "Changes in plasma levels of acute phase proteins in pancreatitis" 42 : 23-30, 2000

85 Wu BU, "Blood urea nitrogen in the early assessment of acute pancreatitis : an international validation study" 171 : 669-676, 2011

86 Vitale DS, "Blood urea nitrogen elevation is a marker for pediatric severe acute pancreatitis" 48 : 363-366, 2019

87 Polyzogopoulou E, "Baseline hypoxemia as a prognostic marker for pulmonary complications and outcome in patients with acute pancreatitis" 49 : 150-154, 2004

88 Gardner TB, "BUN level as a marker of severity in acute pancreatitis : simple, universal, and accurate : comment on"blood urea nitrogen in the early assessment of acute pancreatitis"" 171 : 676-677, 2011

89 Rahman SH, "Association of antioxidant enzyme gene polymorphisms and glutathione status with severe acute pancreatitis" 126 : 1312-1322, 2004

90 Mofidi R, "Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis" 93 : 738-744, 2006

91 Singh VK, "An assessment of the severity of interstitial pancreatitis" 9 : 1098-1103, 2011

92 Crockett SD, "American Gastroenterological Association Institute guideline on initial management of acute pancreatitis" 154 : 1096-1101, 2018

93 Tenner S, "American College of Gastroenterology guideline : management of acute pancreatitis" 108 : 1400-1416, 2013

94 Singla A, "Admission volume determines outcome for patients with acute pancreatitis" 137 : 1995-2001, 2009

95 Gullo L, "Acute pancreatitis in five European countries : etiology and mortality" 24 : 223-227, 2002

96 Balthazar EJ, "Acute pancreatitis : value of CT in establishing prognosis" 174 : 331-336, 1990

97 Lecesne R, "Acute pancreatitis : interobserver agreement and correlation of CT and MR cholangiopancreatography with outcome" 211 : 727-735, 1999

98 Appelros S, "Activation peptide of carboxypeptidase B and anionic trypsinogen as early predictors of the severity of acute pancreatitis" 88 : 216-221, 2001

99 Knaus WA, "APACHE II : a severity of disease classification system" 13 : 818-829, 1985

100 Forsmark CE, "AGA Institute technical review on acute pancreatitis" 132 : 2022-2044, 2007

101 Imrie CW, "A single-centre doubleblind trial of Trasylol therapy in primary acute pancreatitis" 65 : 337-341, 1978

102 Singh VK, "A prospective evaluation of the bedside index for severity in acute pancreatitis score in assessing mortality and intermediate markers of severity in acute pancreatitis" 104 : 966-971, 2009

103 Choudhuri AH, "A comparison of acute physiology and chronic health evaluation II score and serum procalcitonin change for predicting mortality in acute pancreatitis" 24 : 190-194, 2020

104 Huang QL, "A comparative study of the urinary trypsinogen-2, trypsinogen activation peptide, and the computed tomography severity index as early predictors of the severity of acute pancreatitis" 57 : 1295-1299, 2010

105 Bollen TL, "A comparative evaluation of radiologic and clinical scoring systems in the early prediction of severity in acute pancreatitis" 107 : 612-619, 2012

106 Leppäniemi A, "2019 WSES guidelines for the management of severe acute pancreatitis" 14 : 27-, 2019